Pregled bibliografske jedinice broj: 543896
Role of H. pylori eradication therapy success on five year dynamics of dysplasia
Role of H. pylori eradication therapy success on five year dynamics of dysplasia // Helicobacter, 16, Suppl 1 / David Y Graham (ur.).
Cambridge: John Wiley & Sons, 2011. str. 80-80 (predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 543896 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Role of H. pylori eradication therapy success on five year dynamics of dysplasia
Autori
Filipec Kanizaj, Tajana ; Katicic, Miroslava ; Skurla, Bruno ; Prskalo, Marija ; Colic Cvrlje, Vesna ; Naumovski Mihalic, Slavica ; Mrzljak, Anna ; Bradic, Tihomir ; Sobocan, Nikola
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Helicobacter, 16, Suppl 1
/ David Y Graham - Cambridge : John Wiley & Sons, 2011, 80-80
Skup
24 International Workshop on Helicobacter and Related Bacteria in Chronic Digestive Inflammation and Gastric Cancer
Mjesto i datum
Dublin, Irska, 11.09.2011. - 13.09.2011
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
dysplasia; eradication therapy; H. pylori
Sažetak
Aim: to investigate the role of eradication therapy success on five year dynamics of dysplasia. Materials and methods: study was performed on 41 H. pylori positive patients with dysplasia in basic bioptic specimens analyzed according to updated Sydney protocol. All patients received triple eradication therapy. Therapy success and dynamics of dysplasia were evaluated according to 5th year histological finding. Results: basically 41 patients had dysplasia in corpus and/or antrum. Grade I 7, 31%, grade II 39, 02% and grade III 53, 65% of patients. H. pylori was successfully eradicated in 37 patients (90, 24%). In successfully eradicated, complete regression of dysplastic changes appeared in 33/37 (90, 89%) of patients. In all of rest 3 eradicated patients regression of grade of dysplasia was observed. In 2 of 4 non- eradicated patients complete regression of dysplasia and for rest 2 only regression of grade of dysplasia appeared. Statistically significant dynamics of grade of dysplasia was observed for successfully eradicated patients (Wilcox rank sum test, p<0, 001). The difference in proportion of patients with complete regression of dysplasia between eradicated and non - eradicated is statistically significant. Conclusions: In five year interval, proportion of patents with complete regression of dysplasia is statistically significantly higher in successfully eradicated patients than non- eradicated. In both groups regression of grade of dysplasia (and no progression) was observed with application of eradication therapy.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
108-0000000-3114 - HELICOBAKTER PYLORI INFEKCIJA - EVOLUCIJA BOLESTI I NOVI TERAPIJSKI POSTUPCI (Katičić, Miroslava, MZOS ) ( CroRIS)
108-1081873-1893 - Prognostički faktori, dijagnostika i terapija hemoblastoza (Jakšić, Branimir, MZOS ) ( CroRIS)
Ustanove:
Klinička bolnica "Merkur",
Medicinski fakultet, Zagreb
Profili:
Anna Mrzljak
(autor)
Marija Prskalo
(autor)
Nikola Sobočan
(autor)
Miroslava Katičić
(autor)
Slavica Naumovski-Mihalić
(autor)
Tajana Filipec Kanižaj
(autor)
Vesna Čolić-Cvrlje
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE